This issue of Advances in Molecular Pathology will provide a comprehensive review of the most current practices, trends, and developments in the field of Molecular Pathology. Publishing on an annual basis, the volume will be divided into 7 sections: Genetics, Hematopathology, Infectious Disease, Pharmacogenomics, Informatics, Solid tumors, and Identity/HLA. Led by Dr. Gregory Tsongalis of Dartmouth University, a team of experienced pathologists from institutions across the country oversee annual topic and expert author selection.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Editorial Board - p. iii 6. Contributors - p. v 7. Erratum - p. xv 8. Preface - p. xvii 9. Genetics - p. xviii 10. The Evolution of Constitutional Sequence Variant Interpretation - p. 1 11. The Future of Clinical Diagnosis: Moving Functional Genomics Approaches to the Bedside - p. 13 12. Genomic Data in the Electronic Health Record - p. 21 13. Hematopathology - p. 33 14. Molecular Genetics in Myelodysplasia Outcomes Prognostication - p. 35 15. Assessing Measurable Residual Disease in Acute Myeloid Leukemia - p. 45 16. Philadelphia-Like Lymphoblastic Leukemia: Approach to Testing in Clinical Laboratories for Diagnosis, Prognosis, and Therapeutic Risk Assessment - p. 59 17. Myeloid Gene Panel Testing with Correlation to Updated Clinical Practice Guidelines - p. 65 18. Infectious Disease - p. 75 19. Impact of Molecular Diagnostics on Antimicrobial Stewardship - p. 77 20. Application of Next-Generation Sequencing in Public Health Epidemiology and Outbreak Investigation - p. 89 21. Next-Generation Sequencing Approaches to Predicting Antimicrobial Susceptibility Testing Results - p. 99 22. Pharmacogenomics - p. 110 23. Artificial Intelligence and Pharmacogenomics: A Timely Synergy for Individualizing Medicine - p. 111 24. The Evolution of DNA Sequencing in Pharmacogenomics - p. 119 25. Consumer-initiated Genetic Testing and Pharmacogenomics - p. 133 26. Informatics - p. 142 27. Machine Learning in Biology and Medicine - p. 143 28. Solid Tumors - p. 143 29. Clinical Use of Cell-Free DNA in Tumor Diagnostics - p. 153 30. Practical Concepts, Current Challenges, and Technological Advances in Clinical Next-Generation Sequencing Assays for Solid Tumors - p. 163 31. Evidence Builds for Tumor Mutation Burden as an Immunotherapy Biomarker - p. 177 32. Identify/HLA - p. 185 33. Human Leukocyte Antigen Typing Using High-Throughput DNA and RNA Sequencing and Application for Cell Line Identification - p. 187 34. Expanding the Connectivity Map Concept as the Functional Look-Up Table for Systems Biology - p. 201
No hay muestra disponible
No hay ficha técnica disponible
This issue of Advances in Molecular Pathology will provide a comprehensive review of the most current practices, trends, and developments in the field of Molecular Pathology. Publishing on an annual basis, the volume will be divided into 7 sections: Genetics, Hematopathology, Infectious Disease, Pharmacogenomics, Informatics, Solid tumors, and Identity/HLA. Led by Dr. Gregory Tsongalis of Dartmouth University, a team of experienced pathologists from institutions across the country oversee annual topic and expert author selection.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Editorial Board - p. iii 6. Contributors - p. v 7. Erratum - p. xv 8. Preface - p. xvii 9. Genetics - p. xviii 10. The Evolution of Constitutional Sequence Variant Interpretation - p. 1 11. The Future of Clinical Diagnosis: Moving Functional Genomics Approaches to the Bedside - p. 13 12. Genomic Data in the Electronic Health Record - p. 21 13. Hematopathology - p. 33 14. Molecular Genetics in Myelodysplasia Outcomes Prognostication - p. 35 15. Assessing Measurable Residual Disease in Acute Myeloid Leukemia - p. 45 16. Philadelphia-Like Lymphoblastic Leukemia: Approach to Testing in Clinical Laboratories for Diagnosis, Prognosis, and Therapeutic Risk Assessment - p. 59 17. Myeloid Gene Panel Testing with Correlation to Updated Clinical Practice Guidelines - p. 65 18. Infectious Disease - p. 75 19. Impact of Molecular Diagnostics on Antimicrobial Stewardship - p. 77 20. Application of Next-Generation Sequencing in Public Health Epidemiology and Outbreak Investigation - p. 89 21. Next-Generation Sequencing Approaches to Predicting Antimicrobial Susceptibility Testing Results - p. 99 22. Pharmacogenomics - p. 110 23. Artificial Intelligence and Pharmacogenomics: A Timely Synergy for Individualizing Medicine - p. 111 24. The Evolution of DNA Sequencing in Pharmacogenomics - p. 119 25. Consumer-initiated Genetic Testing and Pharmacogenomics - p. 133 26. Informatics - p. 142 27. Machine Learning in Biology and Medicine - p. 143 28. Solid Tumors - p. 143 29. Clinical Use of Cell-Free DNA in Tumor Diagnostics - p. 153 30. Practical Concepts, Current Challenges, and Technological Advances in Clinical Next-Generation Sequencing Assays for Solid Tumors - p. 163 31. Evidence Builds for Tumor Mutation Burden as an Immunotherapy Biomarker - p. 177 32. Identify/HLA - p. 185 33. Human Leukocyte Antigen Typing Using High-Throughput DNA and RNA Sequencing and Application for Cell Line Identification - p. 187 34. Expanding the Connectivity Map Concept as the Functional Look-Up Table for Systems Biology - p. 201
No hay muestra disponible
No hay ficha técnica disponible
